116 related articles for article (PubMed ID: 17032405)
1. Quantitative assessment of liver fibrosis: a novel automated image analysis method.
Matalka II; Al-Jarrah OM; Manasrah TM
Liver Int; 2006 Nov; 26(9):1054-64. PubMed ID: 17032405
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.
Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ
Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512
[TBL] [Abstract][Full Text] [Related]
3. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C.
Lazzarini AL; Levine RA; Ploutz-Snyder RJ; Sanderson SO
Liver Int; 2005 Dec; 25(6):1142-9. PubMed ID: 16343064
[TBL] [Abstract][Full Text] [Related]
4. Sampling variability of liver fibrosis in chronic hepatitis C.
Bedossa P; Dargère D; Paradis V
Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056
[TBL] [Abstract][Full Text] [Related]
5. Simplified method of hepatic fibrosis quantification: design of a new morphometric analysis application.
Friedenberg MA; Miller L; Chung CY; Fleszler F; Banson FL; Thomas R; Swartz KP; Friedenberg FK
Liver Int; 2005 Dec; 25(6):1156-61. PubMed ID: 16343066
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of liver fibrosis in chronic hepatitis C with a computer-assisted morphometric method.
Maduli E; Andorno S; Rigamonti C; Capelli F; Morelli S; Colombi S; Nicosia G; Boldorini R; Abate M; Sartori M
Ann Ital Med Int; 2002; 17(4):242-7. PubMed ID: 12532562
[TBL] [Abstract][Full Text] [Related]
7. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability.
Lee HS; Shun CT; Chiou LL; Chen CH; Huang GT; Sheu JC
J Gastroenterol Hepatol; 2005 Jul; 20(7):1109-14. PubMed ID: 15955222
[TBL] [Abstract][Full Text] [Related]
9. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations].
Jin SY
Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187
[TBL] [Abstract][Full Text] [Related]
10. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
[TBL] [Abstract][Full Text] [Related]
11. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
12. Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors.
Piscaglia F; Cucchetti A; Benlloch S; Vivarelli M; Berenguer J; Bolondi L; Pinna AD; Berenguer M
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1255-61. PubMed ID: 17099373
[TBL] [Abstract][Full Text] [Related]
13. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
14. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
[TBL] [Abstract][Full Text] [Related]
15. Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies.
Turlin B; Ramm GA; Purdie DM; Lainé F; Perrin M; Deugnier Y; Macdonald GA
Liver Int; 2009 Apr; 29(4):530-5. PubMed ID: 19018987
[TBL] [Abstract][Full Text] [Related]
16. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
17. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease.
Fiel MI; Sauter B; Wu HS; Rodriguez-Laiz G; Gondolesi G; Iyer K; Schiano TD
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):926-33. PubMed ID: 18674734
[TBL] [Abstract][Full Text] [Related]
18. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
19. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
[TBL] [Abstract][Full Text] [Related]
20. [Transient elastography for diagnosing liver fibrosis].
Mössner BK; Pedersen C; Christensen PB
Ugeskr Laeger; 2008 Aug; 170(33):2453-6. PubMed ID: 18761829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
